Skip to content
Disclosery

MARSHALL WACE, LLP: TGEN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on TGEN, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 54,806 TGEN shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 54,806 shares
    Change vs previous 13F -152,661 shares

    <0.01% of the 13F portfolio, value $286,087.

    13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 207,467 shares
    Change vs previous 13F -78,858 shares

    <0.01% of the 13F portfolio, value $531,114.

    13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 286,325 shares
    Change vs previous 13F +237,236 shares

    <0.01% of the 13F portfolio, value $1,414,446.

    13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 49,089 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $432,474.

    13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).